78 kDa Glucose-Regulated Protein Attenuates Protein Aggregation and Monocyte Adhesion Induced by Angiotensin II in Vascular Cells.
Angiotensin II
/ metabolism
Animals
Cell Adhesion
Cell Line
Cells, Cultured
Endoplasmic Reticulum Chaperone BiP
Endoplasmic Reticulum Stress
Glucose
/ metabolism
Heat-Shock Proteins
/ genetics
Male
Monocytes
/ cytology
Muscle, Smooth, Vascular
/ cytology
Protein Aggregates
Proteostasis
Rats, Sprague-Dawley
Up-Regulation
Vascular Remodeling
ER stress
angiotensin II
inflammation
protein aggregation
vascular smooth muscle cells
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
15 Jul 2020
15 Jul 2020
Historique:
received:
22
06
2020
revised:
10
07
2020
accepted:
13
07
2020
entrez:
19
7
2020
pubmed:
19
7
2020
medline:
20
2
2021
Statut:
epublish
Résumé
Investigations of vascular smooth muscle cell (VSMC) phenotypic modulation due to angiotensin II (AngII) stimulation are important for understanding molecular mechanisms contributing to hypertension and associated vascular pathology. AngII induces endoplasmic reticulum (ER) stress in VSMCs, which has been implicated in hypertensive vascular remodeling. Under ER stress, 78 kDa glucose-regulated protein (GRP78) acts as an endogenous chaperone, as well as a master controller of unfolded protein response (UPR) to maintain protein quality control. However, the potential downstream consequences of ER stress induced by AngII on protein quality control and pro-inflammatory phenotype in VSMCs remain elusive. This study aims to identify protein aggregation as evidence of the disruption of protein quality control in VSMCs, and to test the hypothesis that preservation of proteostasis by overexpression of GRP78 can attenuate the AngII-induced pro-inflammatory phenotype in VSMCs. Increases in protein aggregation and enhanced UPR were observed in VSMCs exposed to AngII, which were mitigated by overexpression of GRP78. Moreover, GRP78 overexpression attenuated enhanced monocyte adhesion to VSMCs induced by AngII. Our results thus indicate that the prevention of protein aggregation can potentially mitigate an inflammatory phenotype in VSMCs, which may suggest an alternative therapy for the treatment of AngII-associated vascular disorders.
Identifiants
pubmed: 32679678
pii: ijms21144980
doi: 10.3390/ijms21144980
pmc: PMC7403992
pii:
doi:
Substances chimiques
Endoplasmic Reticulum Chaperone BiP
0
Heat-Shock Proteins
0
Protein Aggregates
0
Angiotensin II
11128-99-7
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NHLBI NIH HHS
ID : HL133248
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS109382
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL133248
Pays : United States
Organisme : NINDS NIH HHS
ID : NS109382
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK111042
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK111042
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL128324
Pays : United States
Références
Amyloid. 2020 Jun;27(2):73-80
pubmed: 31825676
Cardiovasc Res. 2017 Apr 1;113(5):453-463
pubmed: 28158647
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
J Cell Biol. 2018 Jan 2;217(1):51-63
pubmed: 29127110
Int J Mol Sci. 2015 Jul 28;16(8):17193-230
pubmed: 26225966
Science. 2011 Nov 25;334(6059):1081-6
pubmed: 22116877
J Chem Technol Biotechnol. 2018 Mar;93(3):909-917
pubmed: 29540956
PLoS One. 2012;7(12):e52868
pubmed: 23300799
Sci Rep. 2019 Jun 11;9(1):8481
pubmed: 31186446
Proc Natl Acad Sci U S A. 2009 May 19;106(20):8326-31
pubmed: 19416856
Endocrinology. 1994 Jan;134(1):222-8
pubmed: 8275937
Hypertension. 2016 May;67(5):1006-13
pubmed: 26975704
Biochem Biophys Res Commun. 2013 May 31;435(2):171-5
pubmed: 23665024
J Cardiovasc Pharmacol. 2020 Jun;75(6):603-607
pubmed: 32168154
Curr Top Med Chem. 2019;19(21):1902-1917
pubmed: 31109279
Cardiovasc Res. 2020 May 08;:
pubmed: 32384150
Sci Rep. 2017 Mar 23;7:44723
pubmed: 28333162
Nat Commun. 2019 Jan 14;10(1):187
pubmed: 30643122
Neurosci Lett. 2012 May 16;516(2):182-7
pubmed: 22490889
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):E1395-E1404
pubmed: 28137856
Trends Pharmacol Sci. 2019 Sep;40(9):684-695
pubmed: 31377018
Nat Cell Biol. 2012 Nov;14(11):1223-30
pubmed: 23103912
Front Genet. 2017 Oct 06;8:126
pubmed: 29085385
Arterioscler Thromb Vasc Biol. 2012 Jul;32(7):1652-61
pubmed: 22539597
Hypertension. 2018 Jul;72(1):235-246
pubmed: 29844144
Am J Physiol Cell Physiol. 2000 Dec;279(6):C1772-81
pubmed: 11078691
Int J Mol Sci. 2020 Apr 28;21(9):
pubmed: 32354103
Am J Physiol Cell Physiol. 2007 Jan;292(1):C82-97
pubmed: 16870827
Cell Rep. 2016 Mar 22;14(11):2611-23
pubmed: 26971994
Endocrinology. 2017 Oct 1;158(10):3162-3173
pubmed: 28938442
Nat Immunol. 2010 May;11(5):411-8
pubmed: 20351694
Circ Res. 2018 Aug 31;123(6):651-653
pubmed: 30355238
Pharmacol Res. 2017 Nov;125(Pt A):4-13
pubmed: 28527699
Methods Mol Biol. 2017;1527:201-211
pubmed: 28116718
J Hypertens. 2016 Aug;34(8):1556-69
pubmed: 27115336
Am J Physiol Heart Circ Physiol. 2013 Aug 1;305(3):H344-53
pubmed: 23709602
Hypertension. 2018 Sep;72(3):537-548
pubmed: 29987104
Am J Hypertens. 2019 Jul 17;32(8):709-719
pubmed: 30982879
Am J Respir Cell Mol Biol. 2012 Jan;46(1):14-22
pubmed: 21778413
Circ Res. 2018 May 25;122(11):1545-1554
pubmed: 29669712
Cells. 2020 Mar 12;9(3):
pubmed: 32178254
Hypertension. 2014 Mar;63(3):e40-5
pubmed: 24379182
Nature. 2016 Apr 21;532(7599):394-7
pubmed: 27007849
Hypertension. 2015 Jun;65(6):1349-55
pubmed: 25916723
Physiol Rev. 2018 Jul 1;98(3):1627-1738
pubmed: 29873596
Front Pharmacol. 2019 Sep 10;10:977
pubmed: 31551782
PLoS One. 2015 Mar 06;10(3):e0119533
pubmed: 25745858
J Biol Chem. 1998 Apr 10;273(15):8890-6
pubmed: 9535870
Am J Hypertens. 2012 Mar;25(3):280-3
pubmed: 22113169